Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPX-351 in Secondary Myeloid Neoplasms
NCT05656248Phase 2Active, not recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Jan 2023
- Primary completion
- Aug 2025
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of cytarabine in myeloid neoplasm, sponsored by St. Jude Children's Research Hospital. Started Jan 2023; status: active, not recruiting.
02
Drugs
cytarabine
03
Conditions
myeloid neoplasm
Beyond the preview
Go deeper on NCT05656248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05656248.